Headquarters
329 OYSTER POINT BLVD FL 3, SOUTH SAN FRANCISCO, CA 94080-1913, US
SOUTH SAN FRANCISCO, CA, US
ENDURA THERAPEUTICS INC
From the company
Endura Therapeutics is an RNA covalency company developing small molecule drugs that form a permanent covalent bond with mRNA, blocking translation and knocking down disease-causing proteins. The company pioneers chemo-genomics, combining Enduring Chemistry with next-generation sequencing to quantify binding in cells at single-nucleotide resolution through its TRANSCEND platform. It targets diseases that can't be treated at the protein level, including cancers such as STAT3 and SMARCA2/4 lung cancer, and neurodegeneration from repeat expansions. Based in
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.